Community of Practice
The adoption of In Silico Trials is a disruptive change and, like all major changes, it encounters some resistance.
To overcome this resistance, we thought of a safe, pre-competitive space where all experts and practitioners from academia, industry and regulatory agencies can ask for advices, exchange information, develop best practices and discuss anything else that can make the use of In Silico Trials an accepted practice.
The community is configured like a forum where members can join teams and collaboratively work on shared goals, projects, concerns, problems or topics.
The community is invitation-only: in this way we assure that only experts with professional interest in in silico medicine have access to the channels and resources.